MEDIATION OF ANTIBODY INDUCED GLOMERULAR INJURY
MEDIATION OF ANTIBODY INDUCED GLOMERULAR INJURY
批准号:
2016076
负责人:
DAVID J SALANT
金额:
$30.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-07-01 至 2001-03-31
关键词:
animal tissue antigen antibody reaction basement membrane biological signal transduction collagen complement cytoskeleton cytotoxicity disease /disorder model enzyme linked immunosorbent assay epithelium extracellular matrix proteins high performance liquid chromatography immunoelectron microscopy in situ hybridization injury integrins laboratory rat membrane permeability membranous glomerulonephritis phosphorylation protein metabolism proteinuria renal glomerulus second messengers tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from Investigators Abstract): This application
proposes to examine the phenomenon of antibody-induced glomerular injury
that can occur in the absence of complement fixation. The investigator has
previously determined that sheep nephrotoxic serum induces proteinuria in
rats and mice in the absence of complement fixation in the glomerulus, and
has further demonstrated that a major target of this polyclonal antibody is
beta1 integrins in glomerular epithelial cells. The goal of the present
studies is to determine whether the anti-beta1 integrin activity of this
nephrotoxic serum is necessary and sufficient to produce the observed
proteinuria, or whether there are additional or alternative antigens
responsible for this effect. The first specific aim will examine whether
the anti beta1 integrin antibody activity is necessary and sufficient to
induce the glomerular injury. This will be purified using immunoabsorption
techniques and in addition, antibodies will be produced to fusion proteins
of external domains of beta1 integrin and alpha3 integrin (the likely alpha
partner to the beta1 integrin in glomerular epithelial cells), and the
nephrotoxicity of these antibodies will be tested in vivo, and will also be
important in initial attempts to map the pathogenic epitope of the
nephrotoxic serum, if indeed the beta1 integrin is determined to be the
major or only antigenic site. The second specific aim examines the
possibility that anti-integrin properties of nephrotoxic serum may be
necessary but insufficient to cause renal injury, or is an epiphenomenon.
These experiments are designed to determine how other as yet undefined
glomerular antigens contribute to the nephrogenic effect.
Immunopurification and molecular biological techniques will be used to
identify other possible glomerular cell membrane proteins that may
contribute to the effects. In addition, the possibility that the
noncollagenous domain of the alpha3 chain of type IV collagen will be
examined as a possible antigen. The third specific aim will examine the
hypothesis that the binding of nephrotoxic serum to glomerular epithelial
cells activates events that disrupt glomerular permselectivity by altering
the relationship between the cells and basement membrane. This specific aim
will be important if the experiments in the first specific aim determine
that the anti-integrin effect of nephrotoxic serum is primarily responsible
for the glomerular alterations. In this revised specific aim, studies will
be performed in a cultured system of rat glomerular epithelial cells grown
on permeable supports. Cells exposed to antibodies will be examined for
alterations in distribution and phosphorylation status of proteins that are
involved in integrin mediated formation of cell and cell extracellular
matrix adhesion. The morphology of cytoskeletal elements and the proteins
that link them to integrins will also be examined in relation to the altered
macromolecular permeability induced by nephrotoxic serum. Integrin-related
signaling will be analyzed by phospholipid hydrolysis and second messenger
production. Finally, the investigator will examine whether there is antigen
shedding after exposure to antibody, or whether the antigen is endocytosed
in response to antibody. These studies are designed to investigate further,
the role of the glomerular epithelial cell as a primary target of injury in
proteinuric renal diseases, and to define the role of integrins in the
maintenance of normal glomerular structure and function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of PLA2R and anti-PLA2R in idiopathic membranous nephropathy
-
批准号:8515398
-
项目类别:
-
资助金额:$35.47万
-
财政年份:2011
-
负责人:DAVID J SALANT
-
依托单位:
Role of PLA2R and anti-PLA2R in idiopathic membranous nephropathy
-
批准号:8322798
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2011
-
负责人:DAVID J SALANT
-
依托单位:
Role of PLA2R and anti-PLA2R in idiopathic membranous nephropathy
-
批准号:8181626
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2011
-
负责人:DAVID J SALANT
-
依托单位:
Role of PLA2R and anti-PLA2R in idiopathic membranous nephropathy
-
批准号:8702155
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2011
-
负责人:DAVID J SALANT
-
依托单位:
Podocyte-specific human PLA2R transgenic mouse model of membranous nephropathy
-
批准号:7976290
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2010
-
负责人:DAVID J SALANT
-
依托单位:
Podocyte-specific human PLA2R transgenic mouse model of membranous nephropathy
-
批准号:8103239
-
项目类别:
-
资助金额:$20.91万
-
财政年份:2010
-
负责人:DAVID J SALANT
-
依托单位:
Identification of The Membranous Nephropathy Antigen
-
批准号:6865436
-
项目类别:
-
资助金额:$23.35万
-
财政年份:2004
-
负责人:DAVID J SALANT
-
依托单位:
Identification of The Membranous Nephropathy Antigen
-
批准号:6783756
-
项目类别:
-
资助金额:$20.93万
-
财政年份:2004
-
负责人:DAVID J SALANT
-
依托单位:
MEDIATION OF ANTIBODY INDUCED GLOMERULAR INJURY
-
批准号:6478975
-
项目类别:
-
资助金额:$5.36万
-
财政年份:2000
-
负责人:DAVID J SALANT
-
依托单位:
MEDIATION OF ANTIBODY INDUCED GLOMERULAR INJURY
-
批准号:6345251
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2000
-
负责人:DAVID J SALANT
-
依托单位:
MEDIATION OF ANTIBODY INDUCED GLOMERULAR INJURY
-
批准号:6206446
-
项目类别:
-
资助金额:$0.31万
-
财政年份:1999
-
负责人:DAVID J SALANT
-
依托单位:
BIOLOGY OF NEPHRITOGENIC GLOMERULAR EPITHELIAL ANTIGEN
-
批准号:2458841
-
项目类别:
-
资助金额:$28.08万
-
财政年份:1994
-
负责人:DAVID J SALANT
-
依托单位:
BIOLOGY OF NEPHRITOGENIC GLOMERULAR EPITHELIAL ANTIGEN
-
批准号:2749517
-
项目类别:
-
资助金额:$28.97万
-
财政年份:1994
-
负责人:DAVID J SALANT
-
依托单位:
BIOLOGY OF NEPHRITOGENIC GLOMERULAR EPITHELIAL ANTIGEN
-
批准号:2148396
-
项目类别:
-
资助金额:$24.16万
-
财政年份:1994
-
负责人:DAVID J SALANT
-
依托单位:
BIOLOGY OF NEPHRITOGENIC GLOMERULAR EPITHELIAL ANTIGEN
-
批准号:2148397
-
项目类别:
-
资助金额:$24.88万
-
财政年份:1994
-
负责人:DAVID J SALANT
-
依托单位:
BIOLOGY OF NEPHRITOGENIC GLOMERULAR EPITHELIAL ANTIGEN
-
批准号:2148398
-
项目类别:
-
资助金额:$25.45万
-
财政年份:1994
-
负责人:DAVID J SALANT
-
依托单位:
MEDIATION OF ANTIBODY-INDUCED GLOMERULAR INJURY
-
批准号:2138533
-
项目类别:
-
资助金额:$32.73万
-
财政年份:1982
-
负责人:DAVID J SALANT
-
依托单位:
MEDIATION OF ANTIBODY-INDUCED GLOMERULAR INJURY
-
批准号:3229740
-
项目类别:
-
资助金额:$20.47万
-
财政年份:1982
-
负责人:DAVID J SALANT
-
依托单位:
Antibody Mediated Glomerular Injury
-
批准号:7188957
-
项目类别:
-
资助金额:$32.05万
-
财政年份:1982
-
负责人:DAVID J SALANT
-
依托单位:
Antibody Mediated Glomerular Injury
-
批准号:7541390
-
项目类别:
-
资助金额:$31.41万
-
财政年份:1982
-
负责人:DAVID J SALANT
-
依托单位:
海外基金